An experimental new urine test can reveal if men with early prostate cancer will probably need aggressive therapy or can be left untreated but monitored, UK researchers say.

Axar.az reports citing BBC.

Current PSA blood tests cannot do this, meaning many men experience unnecessary worry, investigations and treatment.

The prostate urine risk (PUR) test looks for genetic markers to give a more accurate assessment.

Trials in 537 patients suggest it can reliably sort men by risk.

It is one of a number of new tests - including other urine-based ones, as well as blood tests and scans - scientists are pursuing to improve prostate cancer detection.

A combination of checks rather than one single test may ultimately prove to be the best approach, experts say.